- Major
first-mover advantage in proprietary web-based e-commerce platform segment
- Penetrating
U.S. independent pharmacy market with total purchases of $92 billion per
annum
- Adding
100+ pharmacies per month to its online purchasing platform
Trxade Group Inc. (NASDAQ: MEDS), an integrated drug
delivery, procurement, and health care platform that offers health care buyers
and sellers of pharmaceuticals procurement, currently has more than 11,900
pharmacies as registered users of its proprietary e-commerce platform.
Registered users are under no contract of fee obligations when joining the
‘Supplier-to-Pharmacy’ (S2P) trading platform.
With the current number of users already on the network –
serving an estimated 12 to 15 million patients indirectly through these member
pharmacies , and adding about 100 new pharmacies per month, Trxade’s goal is to
reach most, if not all, of the 24,000 independent pharmacies in the U.S., which
have a combined annual purchasing power of more than $92 billion.
Leveraging a robust technology with optimum buyer/seller
pricing algorithms, product availability, and predictive data analytics
features, the platform is designed to help independent pharmacies identify the
best available supplier prices for prescription drugs nationwide. The
platform allows its members to easily compare the price of drugs offered by
various suppliers and select the most favorable deals, saving them money by
taking advantage of best purchase pricing.
This approach is part of Trxade’s efforts to be one of the
driving forces behind a nationwide reduction of pharmaceutical and health care
costs. To this end, the company is committed to developing its portfolio of
products and services to drive value and growth for all members, employees and
investors. Trading platform aside, Trxade also owns a mail order pharmacy and
warehouse and drug delivery service through our Delivemeds (www.Delivmeds.com) and
Bonum Health (www.BonumHealth.com)
a Telehealth App.
The company recently launched a one-of-a-kind Telehealth
initiative, called the ‘Bonum Health Hub’, together with wholly owned
subsidiary Bonum Health, which partnered with Tampa Bay-based independent
retail pharmacy chain Benzer Pharmacy. Bonum and Benzer will locate the Health
Hubs in urban and rural areas lacking this type of care. The Hubs will provide
capacities and technology to offer care to patients who can afford neither
primary nor collaborative care.
The U.S. health care market is currently valued around $4
trillion. As the general population ages, further growth is expected, which in
turn will have increasing impact on consumers as out-of-pocket expenses rise as
well. Drug costs are expected to increase faster than overall health care costs
and well above inflation. Drug pricing is variable, and reimbursement is
squeezing profits. This provides significant opportunity for the Trxade model
of price visibility and profit optimization.
For more information, visit the company’s website at www.TrxadeGroup.com
NOTE TO INVESTORS: The latest news and updates
relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
